Dermapharm Holding SE (DMPHF)
47.69
0.00 (0.00%)
USD |
OTCM |
Oct 06, 16:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 2.363B |
| 52 Week High (Daily) | |
| 52 Week Low (Daily) | |
| All-Time High (Daily) | |
| Year to Date Total Returns (Daily) | |
| 1 Month Total Returns (Daily) | |
| 1 Year Total Returns (Daily) | 22.83% |
| Valuation | |
| PE Ratio | 14.81 |
| PE Ratio (Forward) | |
| PS Ratio | 1.826 |
| Price to Book Value | 3.850 |
| EV to EBITDA | |
| Dividend | |
|---|---|
| Dividend | 1.004 |
| Dividend Yield (Forward) | |
| Financials | |
| Revenue (5 Year Growth) | |
| Revenue (Quarterly YoY Growth) | |
| EPS Diluted (5 Year Growth) | |
| EPS Diluted (Quarterly YoY Growth) | |
| Debt to Equity Ratio | 2.178 |
| Return on Equity | |
| Return on Assets | |
| Risk | |
| Beta (5Y) | |
| Max Drawdown (5Y) | -- |
Profile
| Dermapharm Holding SE engages in the development, manufacture, and marketing of patent-free pharmaceutical products. It operates through the Branded Pharmaceuticals and Other Healthcare Products, Parallel Import Business, and Herbal Extracts divisions. Its product covers prescription pharmaceuticals (Rx), over-the-counter (OTC) products, medical devices, food supplements, and cosmetics. The company was founded in 1991 and is headquartered in Grunwald, Germany. |
| URL | http://www.ir.dermapharm.de |
| Investor Relations URL | N/A |
| HQ State/Province | Bayern (Bavaria) |
| Sector | Health Care |
| Industry | Pharmaceuticals |
| Equity Style | Small Cap Core |
| Next Earnings Release | Nov. 12, 2026 |
| Last Earnings Release | Aug. 25, 2026 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Jun. 29, 2026 |
Profile
| Dermapharm Holding SE engages in the development, manufacture, and marketing of patent-free pharmaceutical products. It operates through the Branded Pharmaceuticals and Other Healthcare Products, Parallel Import Business, and Herbal Extracts divisions. Its product covers prescription pharmaceuticals (Rx), over-the-counter (OTC) products, medical devices, food supplements, and cosmetics. The company was founded in 1991 and is headquartered in Grunwald, Germany. |
| URL | http://www.ir.dermapharm.de |
| Investor Relations URL | N/A |
| HQ State/Province | Bayern (Bavaria) |
| Sector | Health Care |
| Industry | Pharmaceuticals |
| Equity Style | Small Cap Core |
| Next Earnings Release | Nov. 12, 2026 |
| Last Earnings Release | Aug. 25, 2026 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Jun. 29, 2026 |